Leeds Institute of Cancer and Pathology (LICAP) strategy is to use basic, applied and clinical research in cancer and pathology to lead to improved patient outcomes.
Examples of research having significant impact on cancer patient quality of life and survival include:
- Demonstration of the use of new clinical technology including electronic systems for screening and monitoring patients self-reported symptoms, functioning and quality of life; this research led to patient benefits including improved symptom control, emotional functioning and quality-of-life. In addition this research has informed cancer guidelines and patient care programmes nationally and internationally in Canada and USA.
- Researchers identified the importance having of a disease-free margin around excised rectal cancer tumours and predicting this margin routinely and accurately using simple histopathology and preoperative MRI. The team were instrumental in promoting the adoption of modern techniques to assess quality of surgery by professional organisations around the world. Following adoption of our techniques in England and Scotland, local recurrence has halved with 10% better survival and our methods have also become the gold standard in the treatment of rectal cancer patients around the world.
LICAP provides excellent consultancy to commercial, governmental, voluntary and other not-for-profit organisation where our academics are involved in applying their world-leading research to deliver bespoke services to suit individual business requirements, for example:
- Biomarker discovery and evaluation www.proteomics.leeds.ac.uk
- Pathology Services consultation, reading of biomarkers for the pharmaceutical industry
- Virtual Pathology high resolution 3D imaging of tumours www.virtualpathology.leeds.ac.uk
LICAP actively pursues opportunities for Public Engagement by supporting patient interest groups, being involved in fundraising events and arranging a programme of work experience for secondary school pupils.